As rates of fatty liver disease climb alongside global obesity, a clinical trial has found that the ketogenic diet reduced liver fat by 67 percent — outpacing both the Mediterranean and low-fat diets in this specific measure. The finding does not unseat those other approaches so much as complicate the picture: different diets, it seems, may be suited to different purposes, and the long-celebrated Mediterranean pattern may not be the right tool for every metabolic problem. Science, as ever, is less interested in crowning a winner than in asking more precise questions.
Clinical trial shows ketogenic diet reduces liver fat by 67%, outperforms Mediterranean diet
The ketogenic diet produced a 67% reduction in liver fat
Mark
So the ketogenic diet cut liver fat by 67 percent. That's a big number. What does that mean in practical terms for someone with a fatty liver?
Mimi
It means that if someone's liver is storing excess fat—which happens in non-alcoholic fatty liver disease—switching to a ketogenic diet might clear out a significant portion of that accumulation. The liver is metabolically active, and the way ketogenic eating shifts how the body processes fuel seems to have a direct effect on fat storage there.
Luke
But we need to know: how many people were in this trial? How long did it run? And did they control for weight loss? Because if the keto group lost more weight overall, that could explain the difference in liver fat, and it wouldn't be unique to keto.
Mimi
That's fair. The trial did compare keto against Mediterranean and low-fat diets, so there was a control structure. But you're right that the details matter enormously.
Mark
The Mediterranean diet has been studied for decades and shown to be protective against heart disease. Is this trial saying keto is better overall?
Mimi
Not necessarily. Different diets may excel at different things. The Mediterranean diet might still be superior for cardiovascular outcomes or long-term sustainability. This trial is specifically about liver fat. It's one measure.
Luke
And we don't know if the 67 percent reduction held up over time, or if it was measured at one point. We also don't know if the people on keto experienced any metabolic trade-offs—changes in cholesterol, kidney function, or other markers.
Mark
So what should someone actually do with this information?
Mimi
If you have fatty liver disease and other approaches haven't worked, this suggests ketogenic eating might be worth discussing with your doctor. But it's not a guarantee, and it's not for everyone.
Luke
And the long-term safety data is still incomplete. This is one trial showing one outcome. It's important, but it's not the whole picture.
Le Pouls
- A clinical trial has delivered a striking number — 67 percent reduction in liver fat — that puts the ketogenic diet ahead of two widely endorsed dietary approaches for this particular health marker.
- The result lands as a disruption to decades of dietary consensus, where low-fat eating and the Mediterranean model have shared the spotlight in public health guidance.
- Fatty liver disease, quietly epidemic and linked to insulin resistance and eventual cirrhosis, now has a potential dietary intervention with measurable clinical force.
- Researchers and clinicians are left navigating significant unknowns: participant numbers, study duration, long-term sustainability, and whether weight loss alone explains the difference.
- The ketogenic diet's restrictiveness and incomplete long-term safety profile mean enthusiasm must be tempered — this is a promising signal, not yet a prescription.
As rates of fatty liver disease climb alongside global obesity, a clinical trial has found that the ketogenic diet reduced liver fat by 67 percent — outpacing both the Mediterranean and low-fat diets in this specific measure. The finding does not unseat those other approaches so much as complicate the picture: different diets, it seems, may be suited to different purposes, and the long-celebrated Mediterranean pattern may not be the right tool for every metabolic problem. Science, as ever, is less interested in crowning a winner than in asking more precise questions.
A clinical trial has found that the ketogenic diet reduces liver fat by 67 percent — a margin that surpasses what researchers observed in participants following either the Mediterranean diet or a conventional low-fat approach. The result challenges the assumption that these better-known dietary patterns represent the gold standard for metabolic health across every measure.
The study's central insight is that macronutrient composition — specifically the ketogenic emphasis on fat and protein while sharply restricting carbohydrates — appears to produce a distinct effect on the liver, one that may operate independently of weight loss alone. Fatty liver disease has grown increasingly common as obesity rates have risen, and it can progress silently into inflammation, scarring, and eventually cirrhosis. A dietary tool that addresses it so directly carries real clinical weight.
The Mediterranean diet, long associated with cardiovascular protection and longevity, did not match the ketogenic diet on this particular outcome. Neither did the low-fat approach that shaped nutritional guidance for much of the past half-century. The finding suggests that different diets may excel at different things — and that the best choice for one health marker may not be the best choice for another.
Important details remain unclear: how many participants were enrolled, how long the trial ran, how liver fat was measured, and whether the reduction held over time. The ketogenic diet also carries its own burdens — it is difficult to sustain, raises questions about fiber and micronutrient intake, and its long-term effects on kidney function and cardiovascular health in certain populations are not fully understood.
What the trial opens, more than it closes, is a conversation about whether dietary recommendations for metabolic disease might need to be more targeted — matched not just to a patient's general health profile, but to the specific condition being treated.
A clinical trial has found that the ketogenic diet produces a sharper reduction in liver fat than either the Mediterranean diet or conventional low-fat approaches—a result that challenges the conventional wisdom about which eating patterns work best for metabolic health.
The study measured liver fat accumulation in participants assigned to different dietary regimens. Those following a ketogenic approach saw their liver fat drop by 67 percent. This outcome exceeded what researchers observed in the comparison groups, suggesting that the macronutrient composition of the ketogenic diet—its emphasis on fat and protein while restricting carbohydrates—produces a distinct metabolic effect on the liver itself, independent of weight loss alone.
The Mediterranean diet, long celebrated in public health circles for its cardiovascular benefits and association with longevity, did not achieve the same degree of liver fat reduction in this trial. Neither did the low-fat diet, the approach that has dominated dietary guidance for decades. The finding introduces a wrinkle into the conversation about optimal nutrition: different diets may excel at different health outcomes, and the diet that performs best for one measure—say, heart disease risk—may not be the one that most effectively addresses fatty liver disease.
Fatty liver, whether alcoholic or non-alcoholic in origin, has become increasingly common as obesity rates have climbed. It can progress silently, causing inflammation and scarring without obvious symptoms, eventually leading to cirrhosis. The accumulation of fat in liver cells is also linked to insulin resistance and metabolic dysfunction more broadly. A dietary intervention that reduces liver fat by two-thirds represents a potentially significant clinical tool, particularly for people who have not responded adequately to weight loss alone or who struggle with metabolic syndrome.
The trial's design and participant characteristics matter for interpreting these results. The source material does not specify the number of participants, the duration of the study, whether participants were matched for weight loss across groups, or how liver fat was measured—whether by imaging, biopsy, or other means. These details would shape how confidently clinicians could apply the findings to their own patients. It also remains unclear whether the 67 percent reduction was sustained over time or whether it represents a snapshot at a single measurement point.
The ketogenic diet carries its own considerations. It is restrictive, eliminating entire food groups, and some people find it difficult to maintain long-term. It raises questions about nutrient adequacy, particularly around fiber intake and micronutrient density. Some individuals experience side effects during the adaptation phase. And while this trial suggests benefits for liver fat, the long-term safety profile of ketogenic eating—particularly for kidney function, bone health, and cardiovascular markers in certain populations—remains incompletely understood.
The result does not mean the Mediterranean diet is ineffective or that low-fat diets have no role. It means that for the specific outcome of liver fat reduction, the ketogenic approach outperformed these alternatives in this trial. Whether that translates into better long-term health outcomes, whether it works equally well across different populations, and whether people can sustain it long enough to realize its benefits are questions the trial alone cannot answer. What it does do is open a conversation about whether current dietary recommendations for metabolic disease might benefit from reconsideration, at least for certain patients and certain health markers.
Envie de l'histoire complète ?
Lire l'original sur Google News ↗
Health & Medicine